Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 Jan 1;97(1):244-9.
doi: 10.1172/JCI118398.

Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice

T Tsujinaka  1 , J Fujita, C Ebisui, M Yano, E Kominami, K Suzuki, K Tanaka, A Katsume, Y Ohsugi, H Shiozaki, M Monden
Affiliations

Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice

T Tsujinaka et al. J Clin Invest. .

Abstract

The muscles of IL-6 transgenic mice suffer from atrophy. Experiments were carried out on these transgenic mice to elucidate activation of proteolytic systems in the gastrocnemius muscles and blockage of this activation by treatment with the anti-mouse IL-6 receptor (mIL-6R) antibody. Muscle atrophy observed in 16-wk-old transgenic mice was completely blocked by treatment with the mIL-6R antibody. In association with muscle atrophy, enzymatic activities and mRNA levels of cathepsins (B and L) and mRNA levels of ubiquitins (poly- and mono-ubiquitins) increased, whereas the mRNA level of muscle-specific calpain (calpain 3) decreased. All these changes were completely eliminated by treatment with the mIL-6R antibody. This IL-6 receptor antibody could, therefore, be effective against muscle wasting in sepsis and cancer cachexia, where IL-6 plays an important role.

PubMed Disclaimer

References

    1. J Biochem. 1986 Jul;100(1):35-42 - PubMed
    1. Eur J Cancer. 1976 Jun;12(6):465-73 - PubMed
    1. Biochem J. 1987 Apr 15;243(2):335-43 - PubMed
    1. FEBS Lett. 1987 Oct 19;223(1):69-73 - PubMed
    1. Arch Surg. 1987 Dec;122(12):1396-400 - PubMed

MeSH terms